(Q36644057)

15 August 2017

Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N(2) non-small cell lung cancer (English)

1 reference

15 August 2017

1 reference

1 reference

H Date

1

1 reference

15 August 2017

K Kiura

2

1 reference

15 August 2017

H Ueoka

3

1 reference

15 August 2017

M Tabata

4

1 reference

15 August 2017

M Aoe

5

1 reference

15 August 2017

A Andou

6

1 reference

15 August 2017

T Shibayama

7

1 reference

15 August 2017

N Shimizu

8

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

86

1 reference

15 August 2017

4

1 reference

15 August 2017

530-533

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600117

15 August 2017

0 references

cites work

Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375275

Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375275

Dose-finding study of irinotecan and cisplatin plus concurrent radiotherapy for unresectable stage III non-small-cell lung cancer [seecomments].

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375275

Toxicity and response criteria of the Eastern Cooperative Oncology Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375275

Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375275

Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIA (N2) non-small-cell lung cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375275

Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375275

Postoperative complications after combined neoadjuvant treatment of lung cancer

20 September 2018

1 reference

12 December 2020

Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group

1 reference

12 December 2020

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805

1 reference

12 December 2020

Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung

1 reference

12 December 2020

Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer

1 reference

12 December 2020

Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6600117

1 reference

15 August 2017

1 reference

15 August 2017

1 reference